News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
venBio Global Strategic Fund II L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2022 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Sold 37,430 shares
@ $10.3883, valued at
$388.8k
Sold 27,668 shares
@ $10.3876, valued at
$287.4k
Sold 64,683 shares
@ $10.3823, valued at
$671.6k
|
|
| 04/21/2022 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Sold 399,923 shares
@ $10.4151, valued at
$4.2M
Sold 85,611 shares
@ $10.3887, valued at
$889.4k
Sold 62,200 shares
@ $10.3837, valued at
$645.9k
|
|
| 04/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/06/2020 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 53,731 shares
@ $25.6496, valued at
$1.4M
Sold 28,608 shares
@ $25.9909, valued at
$743.5k
|
|
| 01/14/2020 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 494,000 shares
@ $20.23, valued at
$10M
|
|
| 01/10/2020 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 15,677 shares
@ $19.8606, valued at
$311.4k
|
|
| 01/08/2020 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 42,221 shares
@ $19.6438, valued at
$829.4k
Sold 31,000 shares
@ $20.1661, valued at
$625.1k
|
|
| 01/06/2020 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 23,000 shares
@ $19.9351, valued at
$458.5k
Sold 12,498 shares
@ $19.3002, valued at
$241.2k
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2019 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Bought 250,000 shares
@ $16, valued at
$4M
Converted 3,469,759 shares
@ $0
Converted 235,099 shares
@ $0
Converted 10,666,667 preferred shares
@ $0
Converted 722,737 preferred shares
@ $0 |
|
| 01/29/2018 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Menlo Therapeutics, Inc.|
Txns:
| Bought 265,000 shares
@ $17, valued at
$4.5M
Converted 1,196,552 shares
@ $0
Converted 3,227,700 preferred shares
@ $0 |
|
| 11/13/2017 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Converted 3,451,790 shares
@ $0
Bought 127,515 shares
@ $14, valued at
$1.8M
Converted 6,714,413 preferred shares
@ $0
Converted 648,256 preferred shares
@ $0 |
|
|
|